Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Requires catheterization \>24h hours following incontinence or pelvic reconstructive surgery~Exclusion Criteria:~* Receipt of antibiotics for either prophylaxis or treatment of a known infection during the postoperative hospitalization~* Allergy to sulfonamides or trimethoprim~* Non-English speaking~* Pregnancy~* Breast feeding~* Severe renal impairment (creatinine clearance \<30)~* Patients taking dofetilide, methenamine, procaine, warfarin, procainamide, methotrexate.

- Gender: FEMALE
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Drug (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).